Published in J Cardiovasc Pharmacol on October 01, 2011
Bright spots among the world’s coral reefs. Nature (2016) 2.10
Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol (2010) 1.87
Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial. J Med Internet Res (2013) 1.76
Identification of sister chromatids by DNA template strand sequences. Nature (2009) 1.53
Caffeine attenuates metabolic syndrome in diet-induced obese rats. Nutrition (2012) 1.53
Rodent models for metabolic syndrome research. J Biomed Biotechnol (2010) 1.53
Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res (2011) 1.39
Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. Cell Biochem Biophys (2007) 1.38
High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol (2011) 1.31
Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr (2010) 1.23
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Br J Pharmacol (2010) 1.16
Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J Nutr (2011) 1.14
Progression of kyphosis in mdx mice. J Appl Physiol (1985) (2004) 1.13
Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr (2012) 1.10
Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma. Int J Gynecol Pathol (2005) 1.10
Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res (2011) 1.09
Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur J Nutr (2012) 1.07
Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ (2002) 1.05
The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ (2003) 1.05
Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats. J Cardiovasc Pharmacol (2013) 1.04
Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY. J Natl Cancer Inst (2005) 1.03
Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients (2013) 1.01
Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Curr Pharm Biotechnol (2011) 1.00
Chronic high-carbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiol Endocrinol Metab (2012) 1.00
Potential health benefits of Indian spices in the symptoms of the metabolic syndrome: a review. Indian J Biochem Biophys (2009) 0.98
Lysine acetylation in obesity, diabetes and metabolic disease. Immunol Cell Biol (2011) 0.98
Antibody targeting of B-cell maturation antigen on malignant plasma cells. Mol Cancer Ther (2007) 0.98
Cardiac extracellular matrix: a dynamic entity. Am J Physiol Heart Circ Physiol (2005) 0.98
Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem (2012) 0.98
C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J (2012) 0.97
The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem (2010) 0.97
The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress. Curr Cardiol Rev (2010) 0.97
l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2005) 0.96
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats. J Immunol (2006) 0.95
Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. Am J Physiol Heart Circ Physiol (2006) 0.93
Correlates of putting condoms on after sex has begun and of removing them before sex ends: a study of men attending an urban public STD clinic. Am J Mens Health (2007) 0.93
Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr (2012) 0.93
Lipid redistribution by α-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J Nutr Biochem (2011) 0.93
Comparison of purple carrot juice and β-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr (2010) 0.92
Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism. FASEB J (2013) 0.92
High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol (2011) 0.92
Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. Nutrients (2012) 0.91
An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats. Diabetes (2012) 0.90
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats. Br J Pharmacol (2002) 0.89
A co-occurrence of osteogenesis imperfecta type VI and cystinosis. Am J Med Genet A (2012) 0.88
Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol (2011) 0.88
The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats. Transpl Int (2012) 0.86
L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. Basic Clin Pharmacol Toxicol (2009) 0.86
Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats. Evid Based Complement Alternat Med (2011) 0.86
Effects of red pitaya juice supplementation on cardiovascular and hepatic changes in high-carbohydrate, high-fat diet-induced metabolic syndrome rats. BMC Complement Altern Med (2014) 0.85
Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestine. Clin Exp Pharmacol Physiol (2002) 0.85
Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PLoS One (2013) 0.84
Evaluation of the chronic complications of diabetes in a high fructose diet in rats. Indian J Biochem Biophys (2009) 0.84
Gender differences in metabolic syndrome: a key research issue? Endocr Metab Immune Disord Drug Targets (2011) 0.83
Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats. J Cardiovasc Pharmacol (2011) 0.83
Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury. Am J Physiol Renal Physiol (2014) 0.83
Whole-body vibration effects on bone mineral density in women with or without resistance training. Aviat Space Environ Med (2009) 0.82
Cardiac adaptation to endurance exercise in rats. Mol Cell Biochem (2003) 0.82
Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. Br J Pharmacol (2006) 0.82
Piperine attenuates cardiovascular, liver and metabolic changes in high carbohydrate, high fat-fed rats. Cell Biochem Biophys (2013) 0.82
Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol (2006) 0.82
Adenine-induced chronic kidney and cardiovascular damage in rats. J Pharmacol Toxicol Methods (2013) 0.82
Present and future pharmacotherapy for heart failure. Expert Opin Pharmacother (2002) 0.81
Reversal of cardiac dysfunction by selective ET-A receptor antagonism. Br J Pharmacol (2005) 0.81
Stearoyl-CoA desaturase: a vital checkpoint in the development and progression of obesity. Endocr Metab Immune Disord Drug Targets (2011) 0.81
Cardiovascular effects of the toxin(s) of the Australian paralysis tick, Ixodes holocyclus, in the rat. Toxicon (2004) 0.81
Endurance exercise in a rat model of metabolic syndrome. Can J Physiol Pharmacol (2012) 0.80
Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat. Clin Exp Hypertens (2006) 0.80
Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. Am J Physiol Gastrointest Liver Physiol (2009) 0.80
Pre-existing inflammatory state compromises heat tolerance in rats exposed to heat stress. Am J Physiol Regul Integr Comp Physiol (2006) 0.80
Chronic l-arginine treatment improves metabolic, cardiovascular and liver complications in diet-induced obesity in rats. Food Funct (2012) 0.80
A Regenerative Antioxidant Protocol of Vitamin E and α-Lipoic Acid Ameliorates Cardiovascular and Metabolic Changes in Fructose-Fed Rats. Evid Based Complement Alternat Med (2011) 0.79
Responses to oleic, linoleic and α-linolenic acids in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem (2013) 0.78
Impact of an educational intervention and insurance coverage on patients' preferences to transfer multiple embryos. Reprod Biomed Online (2012) 0.78
Autonomic effects of refractory epilepsy on heart rate variability in children: influence of intermittent vagus nerve stimulation. Dev Med Child Neurol (2011) 0.78
Physiological, sensory, and functional measures in a model of wrist muscle injury and recovery. Physiother Can (2008) 0.78
Seaweeds as potential therapeutic interventions for the metabolic syndrome. Rev Endocr Metab Disord (2013) 0.77
Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats. Basic Clin Pharmacol Toxicol (2012) 0.77
Nutrapharmacology of tocotrienols for metabolic syndrome. Curr Pharm Des (2011) 0.77
Leukaemia inhibitory factor retards the progression of atherosclerosis. Cardiovasc Res (2003) 0.77
Chronic dietary L-arginine down-regulates adenosine receptor and nitric oxide synthase expression in rat heart. Basic Clin Pharmacol Toxicol (2008) 0.77